Report

Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer

See allHide authors and affiliations

Science  14 Apr 2017:
Vol. 356, Issue 6334, pp. 200-205
DOI: 10.1126/science.aak9510

Article Information

vol. 356 no. 6334 200-205

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication September 19, 2016
  • Accepted for publication March 16, 2017

Author Information

  1. Sanja Stevanović1,*,
  2. Anna Pasetto2,
  3. Sarah R. Helman1,
  4. Jared J. Gartner2,
  5. Todd D. Prickett2,
  6. Bryan Howie3,
  7. Harlan S. Robins3,4,
  8. Paul F. Robbins2,
  9. Christopher A. Klebanoff5,6,
  10. Steven A. Rosenberg2,
  11. Christian S. Hinrichs1,*
  1. 1Experimental Transplantation and Immunology Branch, National Cancer Institute, Bethesda, MD 20892, USA.
  2. 2Surgery Branch, National Cancer Institute, Bethesda, MD 20892, USA.
  3. 3Adaptive Biotechnologies, Seattle, WA 98102, USA.
  4. 4Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
  5. 5Center for Cell Engineering and Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  6. 6Parker Institute for Cancer Immunotherapy, New York, NY 10065, USA.
  1. *Corresponding author. Email: sanjastevanovic{at}hotmail.com (S.S.); hinrichs{at}mail.nih.gov (C.S.H.)

AltMetrics

Article usage

AbstractFullPDF
Apr 20171484613782724
May 20171955325753
Jun 2017986204367
Jul 2017941118271
Aug 2017486109152
Sep 201756488161
Oct 201741091155